moxifloxacin has been researched along with Symptom Cluster in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 4 (57.14) | 2.80 |
Authors | Studies |
---|---|
Gümüş, G; Kara, N; Karatas Durusoy, G; Öcal, MC | 1 |
Lončarić, K; Radmilović, M; Tadić, R; Vatavuk, Z | 1 |
Compains Silva, E; Echeverria-Palacios, M; Mozo Cuadrado, M; Zubicoa, A | 1 |
Fanlo, P; Heras-Mulero, H; Plaza-Ramos, P; Zubicoa, A | 1 |
Font Juliá, E; Hernández Pardines, F; Molina Martin, JC; Serra Verdú, MC | 1 |
He, YG; Patel, SB; Reddy, NK | 1 |
Bhattacharya, B; Habr, F; Manlolo, J; Robinson, W | 1 |
7 other study(ies) available for moxifloxacin and Symptom Cluster
Article | Year |
---|---|
Cases of toxic anterior segment syndrome after primary pterygium surgery.
Topics: Anterior Eye Segment; Conjunctiva; Eye Diseases; Fibrin; Formaldehyde; Humans; Hyaluronic Acid; Moxifloxacin; Phacoemulsification; Postoperative Complications; Prednisolone; Pterygium; Syndrome | 2022 |
Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Topics: COVID-19; Glaucoma; Humans; Iris; Iris Diseases; Moxifloxacin; Syndrome; Transillumination | 2023 |
Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection.
Topics: Anti-Bacterial Agents; Humans; Iris; Male; Middle Aged; Moxifloxacin; Syndrome; Transillumination | 2022 |
Bilateral acute iris transillumination syndrome. A case report.
Topics: Acute Disease; Anti-Bacterial Agents; Diagnostic Errors; Female; Glaucoma, Open-Angle; Humans; Iris; Middle Aged; Moxifloxacin; Mydriasis; Respiratory Tract Infections; Syndrome; Uveitis, Anterior | 2018 |
Aqueous humor misdirection syndrome after glaucoma filtering surgery in patient with bilateral acute iris transillumination (BAIT) syndrome.
Topics: Anti-Inflammatory Agents; Aqueous Humor; Atrophy; Combined Modality Therapy; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Iridectomy; Iris; Laser Therapy; Middle Aged; Moxifloxacin; Mydriasis; Phacoemulsification; Postoperative Complications; Prednisone; Syndrome; Trabeculectomy; Vitrectomy | 2018 |
TOXIC POSTERIOR SEGMENT SYNDROME AFTER DROPLESS CATARACT SURGERY WITH COMPOUNDED TRIAMCINOLONE-MOXIFLOXACIN.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Therapy, Combination; Electroretinography; Endophthalmitis; Female; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Posterior Eye Segment; Postoperative Complications; Retrospective Studies; Syndrome; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2020 |
Moxifloxacin associated vanishing bile duct syndrome.
Topics: Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Azithromycin; Bile Duct Diseases; Ceftriaxone; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Syndrome | 2010 |